Sawai and colleagues reported that PD-0332991 inhibition of CDK4/6 efficiently inhibited S-phase entry in a panel of human NOTCH1-mutated T-ALL cell lines and in two primary T-ALL patient samples tested in vitro. This evidence concerns the gene CDK4 and acute lymphoblastic leukemia.